Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Times Interest Earned (2016 - 2018)

Lisata Therapeutics filings provide 9 years of Times Interest Earned readings, the most recent being -$2134.5 for Q2 2018.

  • For the quarter ending Q2 2018, Times Interest Earned fell 5560.87% year-over-year to -$2134.5, compared with a TTM value of -$8210.0 through Mar 2019, down 6827.23%, and an annual FY2018 reading of -$3397.4, down 4554.14% over the prior year.
  • Times Interest Earned hit -$2134.5 in Q2 2018 for Lisata Therapeutics, down from -$1719.7 in the prior quarter.
  • The five-year high for Times Interest Earned was -$11.95 in Q1 2016, with the low at -$2134.5 in Q2 2018.
  • Median Times Interest Earned over the past 5 years was -$44.35 (2015), compared with a mean of -$365.2.
  • The sharpest move saw Times Interest Earned soared 78.81% in 2015, then tumbled 5560.87% in 2018.
  • Year by year, Times Interest Earned stood at -$41.79 in 2014, then plummeted by 199.42% to -$125.13 in 2015, then skyrocketed by 75.37% to -$30.81 in 2016, then crashed by 3925.68% to -$1240.5 in 2017, then tumbled by 72.07% to -$2134.5 in 2018.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$2134.5, -$1719.7, and -$1240.5 for Q2 2018, Q1 2018, and Q4 2017 respectively.